Rule register

Cybersecurity in Medical Devices: Quality Management System Considerations and Content of Premarket Submissions

At a glance

Citation
FDA guidance, Cybersecurity in Medical Devices: Quality Management System Considerations and Content of Premarket Submissions (February 3, 2026; docket FDA-2021-D-1158)
Type
Guidance
Status
Effective (as of November 14, 2026)2 This is final guidance. It states that FDA guidance does not establish legally enforceable responsibilities and that its recommendations are not required unless specific regulatory or statutory requirements are cited.1
Applies to
Devices with cybersecurity considerations, including devices with a device software function or that contain software, firmware or programmable logic, whether or not they are network-enabled; premarket submissions to CDRH or CBER (510(k), De Novo, PMA and PMA supplements, PDP, IDE, HDE, BLA and IND); devices that need no premarket submission; and cyber devices under section 524B.
Sectors
Healthcare
Jurisdiction
United States (federal)

Key dates

Key dates Each date is copied from the source its number links to, checked unless the row shows another date. Upcoming or passed as of .
DateKindWhatWhenSource
KindPublishedWhatFirst version of the final guidance issuedWhenPassedSource3
KindPhase beginsWhatRevised guidance adds Section VII on section 524B and cyber devicesWhenPassedSource3
KindPublishedWhatCurrent version issued, superseding the June 27, 2025 version
FDA's Medical Device Cybersecurity page lists this version under February 2, 2026; the guidance document says it was issued on February 3, 2026, and its guidance page dates it February 2026.
WhenPassedSource1

What it changed

FDA first issued this final guidance on September 27, 2023. The June 27, 2025 version added Section VII on section 524B and cyber devices, and the February 2026 version revised the guidance to align with the Quality Management System Regulation, which incorporates ISO 13485:2016 by reference.

Sources

  1. U.S. Food and Drug Administration. Cybersecurity in Medical Devices: Quality Management System Considerations and Content of Premarket Submissions (guidance document, February 3, 2026). Checked .
  2. U.S. Food and Drug Administration. Cybersecurity in Medical Devices: Quality Management System Considerations and Content of Premarket Submissions (guidance page). Checked .
  3. U.S. Food and Drug Administration. Medical Device Cybersecurity (resources and updates). Checked .

How we source and check every fact: Editorial standards · Corrections

Last reviewed . Statuses and dates change: check the source before you rely on one.

Spotted an error? Tell us and we will check it and correct the entry where needed.